About Biotechnology

 Latest update: May 2022 

With an ever-increasing number of bio-ventures and the establishment of a new ecosystem in the Japanese biotech field, this sector offers many opportunities for European SME companies. Through industrial, academic, government and international collaboration, various programs are being promoted and implemented. Due to Japan’s population aging and the resulting health issues, the pharmaceutical sector remains an especially attractive market, as evidenced by the high number of deals between European investors and Japanese biopharma in 2021.

JBA, 2021 Activity Report
EU-Japan Centre, Report : Japan Bioventures Landscape, 2018
JETRO, Life Sciences: Attractive Sectors, 2021


Table of Contents

  • Overview
  • Government Action
  • Main Players
  • Agriculture and Food Market
  • Pharmaceutical and Medical Market
  • Environmental Biotechnology
  • Bioenergy, Fuel & Refinery
  • Bioplastics
  • Expert Reports & Webinars
  • Annual Report
  • Further Reading
  • Relevant Organisations and Trade Fairs
Please log in for full access
Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

  • EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
  • Japanese Industry and Policy News
  • “About Japan” e-News (Only available for EU companies / EU organisations)
  • Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
  • Tech Transfer Helpdesk Newsletter
1 EUR = 166,940 JPY